Nippon Life Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Nippon Life Insurance's REGN Position: Q4 2017 in Review
Nippon Life Insurance sold out of Regeneron Pharmaceuticals (REGN) in Q4 2017, closing a stake of 6,522 shares — an estimated $2.92M sold.
Nippon Life Insurance first reported a position in REGN in Q3 2013 and held it in 17 quarters. The position peaked at $2.92M in Q3 2017. 639 funds tracked by Wall St. Rank hold REGN as of Q4 2017.
- Nippon Life Insurance reported no remaining Regeneron Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
- Nippon Life Insurance sold 6,522 Regeneron Pharmaceuticals shares in Q4 2017, an estimated $2.92M.
- Nippon Life Insurance first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 17 quarters.
- Nippon Life Insurance's Regeneron Pharmaceuticals position peaked at $2.92M in Q3 2017.
- 639 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2017.
Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.